Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...
Telehealth stock Hims & Hers (HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper ...
The Independent Data Monitoring Committee met this week on February 10, 2025 to evaluate the unblinded safety Phase 2b QUALITY data and recommended to continue the QUALITY extension study as designed- ...
Weight-loss drugs helped Dimpy Kapoor shed 15 kg and reclaim her life. Ozempic and Mounjaro are a lifeline for diabetics and ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.
Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback